This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Biosense Webster (Israel) Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Ahmed Niri: Innovator in Cardiac Signal Analysis
Introduction
Ahmed Niri is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of cardiac signal analysis, particularly through his innovative patent that addresses the identification of cardiac areas exhibiting progressively slowing activation.
Latest Patents
Ahmed Niri holds a patent for a method titled "Identifying and indicating cardiac areas exhibiting progressively slowing activation (PSA)." This method involves receiving a cardiac signal sensed by electrodes located in a patient's heart. The cardiac signal includes various signal components evoked by respective activations. The process includes finding and annotating these signal components, calculating time differences between the annotations and corresponding activations, and identifying one or more cardiac tissue locations that demonstrate progressively slowing activation. The method culminates in presenting an electrophysiological map of the heart, which graphically indicates the identified tissue locations demonstrating PSA. He has 1 patent to his name.
Career Highlights
Ahmed Niri has established himself as a key figure in the medical technology sector. His work at Biosense Webster (Israel) Ltd. has allowed him to focus on advancing cardiac care through innovative technologies. His expertise in analyzing cardiac signals has the potential to improve patient outcomes significantly.
Collaborations
Throughout his career, Ahmed has collaborated with talented professionals in the field, including Einat Shapira and Amir Ben-dor. These collaborations have fostered an environment of innovation and have contributed to the development of cutting-edge solutions in cardiac health.
Conclusion
Ahmed Niri's contributions to cardiac signal analysis through his innovative patent exemplify his commitment to advancing medical technology. His work has the potential to make a significant impact on patient care and outcomes in the field of cardiology.